• Return to Headlines

Uptrend Call Working As Medicines Comp Stock Rises 19.9% (MDCO)

By David Diaz

SmarTrend identified an Uptrend for Medicines Comp (NASDAQ:MDCO) on November 19th, 2019 at $70.84. In approximately 3 months, Medicines Comp has returned 19.86% as of today's recent price of $84.90.

In the past 52 weeks, shares of Medicines Comp have traded between a low of $16.69 and a high of $84.98 and are now at $84.90, which is 409% above that low price. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has remained constant.

The Medicines Company develops products that improve specialized care. The Company markets Angiomax, an anticoagulant approved in the United States and other countries for use in patients undergoing coronary angioplasty procedures.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Medicines Comp shares.

Log in and add Medicines Comp (MDCO) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights medicines comp

Ticker(s): MDCO